Drug Discovery

ClinOps and Medical Affairs: Unlocking Collaboration with MSLs
Research & Development ClinOps and Medical Affairs: Unlocking Collaboration with MSLs

In the intricate world of biopharmaceuticals, where the journey from drug discovery to patient delivery is fraught with challenges, the roles of Clinical Operations (ClinOps) and Medical Affairs (MA) stand out as indispensable. ClinOps serves as the operational backbone, meticulously managing

Why Did Viking's Obesity Pill Fail to Impress Investors?
Research & Development Why Did Viking's Obesity Pill Fail to Impress Investors?

In the fast-evolving landscape of obesity treatment, where pharmaceutical companies race to deliver groundbreaking solutions, Viking Therapeutics emerged with high hopes for their oral weight loss drug, VK2735. Touted as a convenient alternative to injectable therapies dominating the market, this

Can AI Revolutionize Drug Discovery with Recursion Pharmaceuticals?
Research & Development Can AI Revolutionize Drug Discovery with Recursion Pharmaceuticals?

In a world where the intersection of technology and healthcare is becoming ever more critical, Recursion Pharmaceuticals emerges as a trailblazer with a mission to transform the landscape of drug discovery through artificial intelligence (AI). Listed on NASDAQ under the ticker RXRX, this innovative

Scientists Push for Medicine to Target Aging Biology
Research & Development Scientists Push for Medicine to Target Aging Biology

In an era where medical advancements are reshaping how humanity approaches health, a transformative idea is gaining traction among scientists who argue that the key to tackling chronic diseases lies not in treating them individually, but in targeting the very biology of aging itself. This

Can Psychedelics Transform Postpartum Depression Treatment?
Research & Development Can Psychedelics Transform Postpartum Depression Treatment?

What happens when the joy of motherhood is eclipsed by an unyielding fog of despair for nearly half a million women in the U.S. each year? Postpartum depression (PPD), a debilitating condition affecting about 15% of new mothers, often turns a time of bonding into a battle for mental survival. Amid

FDA Approves Sephience for Rare PKU Disorder Treatment
Management & Regulatory FDA Approves Sephience for Rare PKU Disorder Treatment

Imagine living with a condition where even a small bite of protein-rich food could lead to severe neurological damage, a daily reality for thousands of individuals in the U.S. diagnosed with phenylketonuria (PKU), a rare genetic metabolic disorder. Affecting approximately one in every 13,500 to

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later